What does Dr. Spaepen do?

Dr. Spaepen is a specialist medical practice in Hulshout. Private Limited, started on 6 December 2007, 1 establishment.

What is the address of Dr. Spaepen?

The registered office of Dr. Spaepen is located at Ramselsesteenweg 42, 2235 Hulshout.

Is Dr. Spaepen still active?

Yes. According to the CBE (18 September 2026) Dr. Spaepen is active, legal situation “Normale toestand”, started on 6 December 2007.

Is Dr. Spaepen registered on Peppol?

Yes, Dr. Spaepen is registered on the Peppol network with ID 0208:0894003864.

What is the enterprise number of Dr. Spaepen?

The enterprise number of Dr. Spaepen is BE0894003864.

When was Dr. Spaepen founded?

Dr. Spaepen was founded on 6 December 2007.

Who are the directors of Dr. Spaepen?

According to the 2025 annual accounts, the directors of Dr. Spaepen are: Walter Spaepen, Marijke Spaepen.

Is Dr. Spaepen a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 6 December 2007; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did Dr. Spaepen make in 2025?

Dr. Spaepen posted a profit after taxes of € 166,783 in financial year 2025.

What is the revenue of Dr. Spaepen?

As a small company, Dr. Spaepen is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 254,656.

Dr. Spaepen (Private Limited) - Hulshout - BE0894003864

Dossier Dr. Spaepen, printed on 18 September 2026 from databakkes.be/en/0894003864/dr-spaepen. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. Spaepen from Hulshout, company number BE0894003864, closed financial year 2025 with a result of € 166,783 after tax. For that financial year Dr. Spaepen recorded a gross margin of € 254,656 and equity of € 860,145. Compared with financial year 2024, the result moved from € 155,530 to € 166,783. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 23, 2026.

What it is worth Healthy

€ 860,145

▼ 30% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 166,783

▲ 7% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 63,972

▲ 60% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 531,080 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 23,569

▼ 38% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 2 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 24,361

▼ 37% vs 2024

€ 14,483 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.

Owed to suppliers

€ 1,368

▼ 61% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 1,112

▼ 94% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 295,958 Gross margin 2022: € 295,958 First fiscal year in the series	€ 226,233 Gross margin 2023: € 226,233 ▼ 24% vs 2022 (€ 295,958) Unfavourable step	€ 228,144 Gross margin 2024: € 228,144 ▲ 1% vs 2023 (€ 226,233) Favourable step	€ 254,656 Gross margin 2025: € 254,656 ▲ 12% vs 2024 (€ 228,144) Favourable step	▲ 12%
Profit after taxes	€ 208,411 Profit after taxes 2022: € 208,411 First fiscal year in the series	€ 155,911 Profit after taxes 2023: € 155,911 ▼ 25% vs 2022 (€ 208,411) Unfavourable step	€ 155,530 Profit after taxes 2024: € 155,530 Unchanged (€ 155,911) Unfavourable step	€ 166,783 Profit after taxes 2025: € 166,783 ▲ 7% vs 2024 (€ 155,530) Favourable step	▲ 7%
Equity	€ 1,089,001 Equity 2022: € 1,089,001 First fiscal year in the series	€ 1,068,912 Equity 2023: € 1,068,912 ▼ 2% vs 2022 (€ 1,089,001) Unfavourable step	€ 1,224,442 Equity 2024: € 1,224,442 ▲ 15% vs 2023 (€ 1,068,912) Favourable step	€ 860,145 Equity 2025: € 860,145 ▼ 30% vs 2024 (€ 1,224,442) Unfavourable step	▼ 30%
Total debts	€ 117,443 Total debts 2022: € 117,443 First fiscal year in the series	€ 107,184 Total debts 2023: € 107,184 ▼ 9% vs 2022 (€ 117,443) Favourable step	€ 60,580 Total debts 2024: € 60,580 ▼ 43% vs 2023 (€ 107,184) Favourable step	€ 26,842 Total debts 2025: € 26,842 ▼ 56% vs 2024 (€ 60,580) Favourable step	▼ 56%
Cash	€ 45,423 Cash 2022: € 45,423 First fiscal year in the series	€ 132,854 Cash 2023: € 132,854 ▲ 192% vs 2022 (€ 45,423) Favourable step	€ 40,021 Cash 2024: € 40,021 ▼ 70% vs 2023 (€ 132,854) Unfavourable step	€ 63,972 Cash 2025: € 63,972 ▲ 60% vs 2024 (€ 40,021) Favourable step	▲ 60%
Land & buildings	€ 4,734 Land & buildings 2022: € 4,734 First fiscal year in the series	€ 3,945 Land & buildings 2023: € 3,945 ▼ 17% vs 2022 (€ 4,734) Unchanged	€ 3,156 Land & buildings 2024: € 3,156 ▼ 20% vs 2023 (€ 3,945) Unchanged	€ 2,367 Land & buildings 2025: € 2,367 ▼ 25% vs 2024 (€ 3,156) Unchanged	▼ 25%
Retained profit	€ 1,076,601 Retained profit 2022: € 1,076,601 First fiscal year in the series	€ 1,056,512 Retained profit 2023: € 1,056,512 ▼ 2% vs 2022 (€ 1,076,601) Unfavourable step	€ 1,212,042 Retained profit 2024: € 1,212,042 ▲ 15% vs 2023 (€ 1,056,512) Favourable step	€ 847,745 Retained profit 2025: € 847,745 ▼ 30% vs 2024 (€ 1,212,042) Unfavourable step	▼ 30%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 176,000 Dividend 2023: € 176,000 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 176,000) Unchanged	€ 531,080 Dividend 2025: € 531,080 Unchanged (€ 0) Unchanged
Bank debt	€ 65,509 Bank debt 2022: € 65,509 First fiscal year in the series	€ 52,166 Bank debt 2023: € 52,166 ▼ 20% vs 2022 (€ 65,509) Favourable step	€ 38,454 Bank debt 2024: € 38,454 ▼ 26% vs 2023 (€ 52,166) Favourable step	€ 24,361 Bank debt 2025: € 24,361 ▼ 37% vs 2024 (€ 38,454) Favourable step	▼ 37%
Balance sheet total	€ 1,206,444 Balance sheet total 2022: € 1,206,444 First fiscal year in the series	€ 1,176,096 Balance sheet total 2023: € 1,176,096 ▼ 3% vs 2022 (€ 1,206,444) Unchanged	€ 1,285,022 Balance sheet total 2024: € 1,285,022 ▲ 9% vs 2023 (€ 1,176,096) Unchanged	€ 886,986 Balance sheet total 2025: € 886,986 ▼ 31% vs 2024 (€ 1,285,022) Unchanged	▼ 31%

Key figures of Dr. Spaepen, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Spaepen?

What happened at Dr. Spaepen in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 23, 2026 New annual accounts for financial year 2025: profit of € 166,783 (▲ 7% vs 2024). Source: NBB ↗
2024 Marijke Spaepen became a director. NBB
Dec 6, 2007 Start of the company according to the CBE. KBO
Nov 23, 2007 New establishment in Hulshout. KBO
2007 Walter Spaepen became a director. NBB

In short

From € 208,411 profit in 2022 to € 166,783 profit in 2025.

Paid € 335,166 in corporate taxes since 2022.

Best year ever: 2022, with € 208,411 profit.

Paid out € 707,080 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Spaepen? We notify you, reason included.

Follow Dr. Spaepen

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Walter Spaepen Marijke Spaepen

Dr. Spaepen

DOKTER MARIJKE SPAEPEN

Behind Dr. Spaepen are Walter Spaepen and Marijke Spaepen. Marijke Spaepen is also behind DOKTER MARIJKE SPAEPEN.

See the full network in the app

Directors

According to the 2025 annual accounts

Walter Spaepen

Director

since 2007

Marijke Spaepen

Director

Also active at: DOKTER MARIJKE SPAEPEN

since 2024

Establishments

Establishment units

Physical locations of this company

Registered office

Ramselsesteenweg 42

2235 Hulshout

2.186.853.815

Ramselsesteenweg 38

2235 Hulshout

Active since 23 November 2007

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0894.003.864

VAT number

BE 0894.003.864

Registered office

Ramselsesteenweg 42, 2235 Hulshout

Names & denominations

Dr. Spaepen

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

6 December 2007

Peppol

Active · Active since 27 Oct 2025

Activities · NACE

Activiteiten van medisch specialisten

Activiteiten van huisartspraktijken

View on CBE Public ↗ Annual accounts (NBB) ↗

Dr. Spaepen

Financials

What happened to Dr. Spaepen?

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions